Advertisement

Topics

The Lupus Foundation of America Greater Washington Company Profile

20:02 EST 17th November 2017 | BioPortfolio


News Articles [1326 Associated News Articles listed on BioPortfolio]

Lupus Foundation of America Launches Online Lupus Support Community

WASHINGTON, Aug. 29, 2017 /PRNewswire-USNewswire/ -- Today, the Lupus Foundation of America in partnership with Inspire, unveiled LupusConnect™, an online lupus community where individuals with...

Lupus Foundation Of America Release: Lupus Impacts Asian/Pacific Islanders And Hispanics At Alarming Rates

  Life Sciences Jobs   ...

Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today announced it has received this year’s National Corporate Visionary Award from the Lupus Foundation of America. The ...

Lupus Community Prepares to Host Landmark Event to Drive Lupus Therapy Development

WASHINGTON, Sept. 21, 2017 /PRNewswire-USNewswire/ -- The Lupus and Allied Diseases Association, Inc., the Lupus Foundation of America and the Lupus Research Alliance are partnering to convene a day-l...

MUSC leads research on potential research treatment

(Medical University of South Carolina) A five-year, $3.8 million grant from the Lupus Foundation of America funds phase 2 of a clinical trial evaluating a treatment using mesenchymal stem cells harves...

Finding cures for incurable diseases

By Sandra Raymond, president and CEO, The Lupus Foundation of America

Racial and ethnic disparities in lupus rates revealed in new report

Striking racial and ethnic disparities in the incidence and prevalence of lupus are discussed in research in Arthritis & Rheumatology. Based on data from 2.4 million people in San Francisco and Ma...

In young patients with SLE, psychiatric comorbidity linked to greater use of health care

SAN DIEGO — Young patients with systemic lupus erythematosus and co-existing psychiatric conditions appear to have greater health care utilization in ambulatory settings in the year after SLE diagno...

Drugs and Medications [689 Associated Drugs and Medications listed on BioPortfolio]

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Shiseido white lucent brightening spot-control foundation (refill) [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill)

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

PubMed Articles [1575 Associated PubMed Articles listed on BioPortfolio]

Renal outcome after kidney-transplantation in Korean patients with lupus nephritis.

We investigated renal outcome of kidney-transplantation in 19 Korean recipients with biopsy-proven lupus nephritis and compared it with 18 Korean age- and gender-matched recipients without lupus nephr...

Do ANCAs make the difference in lupus nephritis?

There has been much debate as to whether the distinction between lupus nephritis class IV-S and class IV-G is clinically relevant and whether antineutrophil cytoplasmic antibodies are pathomechanistic...

Nurses leading change to advance health.

The article includes a review of selected past and current leadership initiatives as well as a summary of three leadership meetings convened by The Center to Champion Nursing in America, a partnership...

Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.

To compare the clinical course of patients with class III, IV and V lupus nephritis (LN) treated at Hospital Universitario Cruces (CC) and at Bordeaux University Hospital (BC).

Effects of obesity and diabetes on rate of bone density loss.

In this large registry-based study, women with diabetes had marginally greater bone mineral density (BMD) loss at the femoral neck but not at other measurement sites, whereas obesity was not associate...

Clinical Trials [2120 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

This is a Phase II, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rontalizumab compared with placebo in patients with moderately to ...

Duke Lupus Registry

Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common...

An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)

This trial is conducted in Europe and North America. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetic and signs of bioactivity of increasing singl...

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

This trial is conducted in the United States of America (USA). The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics and signs of bioactivity of incre...

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

This clinical study will test the efficacy and safety of nicotinamide for lupus-associated skin lesions refractory to the treatment of hydroxychloroquine plus low-dose corticosteroids in p...

Companies [3142 Associated Companies listed on BioPortfolio]

The Lupus Foundation of America Greater Washington

Lupus Foundation of America Greater Washington Chapter

Lupus Foundation of America Greater Washington Chapter, Inc.

Lupus Foundation of America (LFA)

The Lupus Foundation of America (LFA) is the foremost national nonprofit organization dedicated to finding the causes of and cure for lupus, and providing support, services, and h...

S.L.E. Lupus Foundation

The S.L.E. Lupus Foundation, headquartered in New York City with a West Coast division in Los Angeles, is the country's preeminent nonprofit organization providing direct patient services, education, ...

More Information about "The Lupus Foundation of America Greater Washington" on BioPortfolio

We have published hundreds of The Lupus Foundation of America Greater Washington news stories on BioPortfolio along with dozens of The Lupus Foundation of America Greater Washington Clinical Trials and PubMed Articles about The Lupus Foundation of America Greater Washington for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lupus Foundation of America Greater Washington Companies in our database. You can also find out about relevant The Lupus Foundation of America Greater Washington Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record